^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    RG6286

    i
    Other names: RG6286, BLYG8824A
    Associations
    News
    Trials
    Company:
    Roche
    Drug class:
    CD3 agonist, LY6G6D inhibitor
    Related drugs:
    Associations
    News
    Trials